{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:11:57Z","timestamp":1792023117067,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Squamous cell carcinoma (SCC) is the most common type of penile cancer, and infection with human papillomavirus (HPV) is one of the most highly associated risk factors. The WHO classification for penile SCC (2022) strongly recommends and advocates penile SCC to be reported as HPV-associated or HPV-independent type in pathology reports. Further, p16 immunohistochemistry (IHC) is recommended to classify SCC into the above major types, although it is not completely reliable for HPV infection. Although there are no established differences in the prognosis or treatment between HPV-associated and HPV-independent penile tumours, there is recent evidence to suggest that HPV-associated SCC may respond better to radiation therapy, immunotherapy, etc.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim and objectives<\/jats:title>\n            <jats:p>This study aims to = analyse the clinicopathological features of penile squamous cell carcinoma and reclassify penile SCC into HPV-associated and HPV-independent types to align with the WHO classification of penile carcinoma (2022) and study the expression of p16 by immunohistochemistry. Additionally, we studied the prognostic significance of HPV-associated and independent SCC based on histology and p16 immunostaining.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>This is a five-year retrospective single-institution study that included all diagnosed cases of penile SCC. Clinicopathological features and p16 expressions were studied and analysed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 72 cases of penile SCC were included during the study period. The mean age of occurrence of penile SCC was 58 years. The most common site of the tumor was the glans penis (50.74%). We encountered only 6 cases (8.3%) of HPV-associated type of penile SCC, while the majority belonged to the HPV-independent type (91.7%) based on histology. p16 immunohistochemistry showed positivity in 15 cases (21%) and negativity in 57 cases (79%). Most of the tumors showed favorable features\u2013 histological grade I, pathological T1 stage with a low incidence of nodal metastasis. There was a strong association between histological subtyping into HPV-associated and independent SCC with p16 IHC expression (<jats:italic>p<\/jats:italic>\u2009=\u20090.015). Classification of penile SCC by histology and p16 expression into HPV associated and independent type showed no prognostic significance with pathological stage but was significant with histological grade and lymph node metastasis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13000-025-01676-5","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:12:54Z","timestamp":1751541174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinicopathological features and reclassification of penile squamous cell carcinoma according to WHO classification 2022 for penile carcinoma with p16 immunohistochemical expression and its prognostic impact"],"prefix":"10.1186","volume":"20","author":[{"given":"Vaanya","family":"Kaushik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanthilatha","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"4","key":"1676_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.humpath.2014.12.004","volume":"46","author":"S Bezerra","year":"2015","unstructured":"Bezerra S, Chaux A, Ball M, Faraj S, Munari E, Gonzalez-Roibon N, et al. Human papillomavirus infection and immunohistochemical p16INK4a expression as predictors of outcome in penile squamous cell carcinomas. Hum Pathol. 2015;46(4):532\u201340.","journal-title":"Hum Pathol"},{"issue":"4","key":"1676_CR2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/his.14824","volume":"82","author":"S Menon","year":"2023","unstructured":"Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Comp\u00e9rat E, Hartmann A, Netto G, Rubin MA, Gill AJ, Turajlic S, Tan PH, Raspollini MR, Tickoo SK, Amin MB. WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 2023;82(4):508\u201320.","journal-title":"Histopathology"},{"key":"1676_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","volume":"20","author":"DM Backes","year":"2008","unstructured":"Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control. 2008;20:449\u201357.","journal-title":"Cancer Causes Control"},{"issue":"2","key":"1676_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0094-0143(21)00387-6","volume":"19","author":"JK Burgers","year":"1992","unstructured":"Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am. 1992;19(2):247\u201356.","journal-title":"Urol Clin North Am"},{"issue":"6","key":"1676_CR5","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/bjc.2014.42","volume":"110","author":"GC Larsen","year":"2014","unstructured":"Larsen GC, Gyldenl\u00f8ve M, Jensen DH, Therkildsen MH, Kiss K, Norrild B, et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer. 2014;110(6):1587\u201394.","journal-title":"Br J Cancer"},{"key":"1676_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","volume":"24","author":"N Mu\u00f1oz","year":"2006","unstructured":"Mu\u00f1oz N, Castellsagu\u00e9 X, de Gonz\u00e1lez A, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24:S1\u201310.","journal-title":"Vaccine"},{"key":"1676_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s1470-2045(18)30682-x","volume":"20","author":"TB Olesen","year":"2019","unstructured":"Olesen TB, Sand FL, Rasmussen CL, Albieri V, Toft BG, Norrild B, Munk C, Kj\u00e6r SK. Prevalence of human papillomavirus DNA and p16(ink4a) in penile cancer and penile intraepithelial neoplasia: A systematic review and meta-analysis. Lancet Oncol. 2019;20:145\u201358. https:\/\/doi.org\/10.1016\/s1470-2045(18)30682-x","journal-title":"Lancet Oncol"},{"issue":"1","key":"1676_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.30699\/ijp.2023.1998898.3092","volume":"19","author":"DSA Adiga","year":"2024","unstructured":"Adiga DSA, Manish Sh GV, Ch. Study of expression of P16 in premalignant and malignant lesions of penis and their significance. Iran J Pathol. 2024;19(1):50\u20138.","journal-title":"Iran J Pathol"},{"issue":"8","key":"1676_CR9","first-page":"4049","volume":"17","author":"T Sritippho","year":"2016","unstructured":"Sritippho T, Pongsiriwet S, Lertprasertsuke N, Buddhachat K, Sastraruji T, Iamaroon A. p16 - a possible surrogate marker for High-Risk human papillomaviruses in oral Cancer. Asian Pac J Cancer Prev. 2016;17(8):4049\u201357.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"1676_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0002-9440(10)63871-0","volume":"162","author":"JP Klussmann","year":"2003","unstructured":"Klussmann JP, G\u00fcltekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003;162(3):747\u201353.","journal-title":"Am J Pathol"},{"issue":"4","key":"1676_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00125480-200607000-00006","volume":"13","author":"AN Kalof","year":"2006","unstructured":"Kalof AN, Cooper K. p16INK4aimmunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol. 2006;13(4):190\u20134.","journal-title":"Adv Anat Pathol"},{"issue":"7","key":"1676_CR12","doi-asserted-by":"publisher","first-page":"e0262877","DOI":"10.1371\/journal.pone.0262877","volume":"17","author":"N De Wispelaere","year":"2022","unstructured":"De Wispelaere N, Rico SD, Bauer M, Luebke AM, Kluth M, B\u00fcscheck F, et al. High prevalence of p16 staining in malignant tumours. PLoS ONE. 2022;17(7):e0262877.","journal-title":"PLoS ONE"},{"key":"1676_CR13","doi-asserted-by":"crossref","unstructured":"Christian A, Moen TE, Falkenthal TK, Thorkelsen A, Hopland OE, Rio HN, Dongre DE, Costea. Leif Bostad, Paul Brennan, Mattias Johansson, Aida Ferreiro-Iglesias, Nicole Brenner, Tim Waterboer, Mari Nyg\u00e5rd, Christian Beisland,Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years, European Urology Oncology 2024,7(4) 778\u2013785.","DOI":"10.1016\/j.euo.2023.10.013"},{"key":"1676_CR14","doi-asserted-by":"crossref","unstructured":"Marie-Lisa Eich A, Matoso JB, Gordetsky. Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study, Human Pathology, 96,2020, 79\u201386.","DOI":"10.1016\/j.humpath.2019.09.013"},{"issue":"1","key":"1676_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1186\/s12885-022-10127-z","volume":"15","author":"AAL Teixeira J\u00fanior","year":"2022","unstructured":"Teixeira J\u00fanior AAL, da Costa Melo SP, Pinho JD, et al. A comprehensive analysis of penile cancer in the region with the highest worldwide incidence reveals new insights into the disease. BMC Cancer. 2022;15(1):1063.","journal-title":"BMC Cancer"},{"issue":"4","key":"1676_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4103\/0970-1591.120106","volume":"29","author":"MT Manipadam","year":"2013","unstructured":"Manipadam MT, Bhagat SK, Gopalakrishnan G, Kekre NS, Chacko NK, Prasanna. Samuel. Warty carcinoma of the penis: A clinicopathological study from South India. Indian J Urol. 2013;29(4):282\u20137.","journal-title":"Indian J Urol"},{"issue":"3","key":"1676_CR17","doi-asserted-by":"publisher","first-page":"103007","DOI":"10.1016\/j.labinv.2024.103007","volume":"105","author":"D Bilala","year":"2025","unstructured":"Bilala D, et al. HPV-Associated and HPV-Independent penile squamous cell carcinoma: correlation with histological subtypes and clinical outcomes from a tertiary oncology centre in India laboratory. Investigation. 2025;105(3):103007.","journal-title":"Investigation"},{"issue":"2","key":"1676_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/PAS.0b013e318203cdba","volume":"35","author":"A Cubilla","year":"2011","unstructured":"Cubilla A, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, et al. Value of p16INK4a in the pathology of invasive penile squamous cell carcinomas. Am J Surg Pathol. 2011;35(2):253\u201361.","journal-title":"Am J Surg Pathol"},{"key":"1676_CR19","doi-asserted-by":"crossref","unstructured":"Elst L. Maarten Albersen,Human Papillomavirus: One Less Worry for Men Too?European Urology,2022;81 (6)549\u2013551.","DOI":"10.1016\/j.eururo.2022.03.001"},{"key":"1676_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/LGT.0000000000000159","volume":"20","author":"DS Heller","year":"2016","unstructured":"Heller DS. Lesions and neoplasms of the penis: A review. J Low Genit Tract Dis. 2016;20:107\u201311.","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"1676_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/bjc.2012.583","volume":"108","author":"H Do","year":"2013","unstructured":"Do H, Koriyama C, Khan N, Higashi M, Kato T, Le N, et al. The etiologic role of human papillomavirus in penile cancers: a study in Vietnam. Br J Cancer. 2013;108(1):229\u201333.","journal-title":"Br J Cancer"},{"issue":"10","key":"1676_CR22","doi-asserted-by":"publisher","first-page":"e0205350","DOI":"10.1371\/journal.pone.0205350","volume":"13","author":"V Martins","year":"2018","unstructured":"Martins V, Pinho J, Teixeira J\u00fanior A, Nogueira L, Silva F, Maulen V, et al. P16INK4a expression in patients with penile cancer. PLoS ONE. 2018;13(10):e0205350.","journal-title":"PLoS ONE"},{"key":"1676_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1590\/S1677-55382008000400009","volume":"34","author":"MA Scheiner","year":"2008","unstructured":"Scheiner MA, Campos MM, Ornellas AA, Chin EW, Ornellas MH, Andrada-Serpa MJ. Human papillomavirus and penile cancers in Rio de janeiro, brazil: HPV typing and clinical features. Int Braz J Urol. 2008;34:467\u201376.","journal-title":"Int Braz J Urol"},{"issue":"2","key":"1676_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.juro.2014.08.087","volume":"193","author":"R Djajadiningrat","year":"2015","unstructured":"Djajadiningrat R, Jordanova E, Kroon B, van Werkhoven E, de Jong J, Pronk D, et al. Human papillomavirus prevalence in invasive penile Cancer and association with clinical outcome. J Urol. 2015;193(2):526\u201331.","journal-title":"J Urol"},{"issue":"5","key":"1676_CR25","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/ijc.21961","volume":"119","author":"A Lont","year":"2006","unstructured":"Lont A, Kroon B, Horenblas S, Gallee M, Berkhof J, Meijer C, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006;119(5):1078\u201381.","journal-title":"Int J Cancer"},{"issue":"6","key":"1676_CR26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ad.2011.08.008","volume":"103","author":"C Ferr\u00e1ndiz-Pulido","year":"2012","unstructured":"Ferr\u00e1ndiz-Pulido C, de Torres I, Garc\u00eda-Patos V. Carcinoma Escamoso de Pene. Actas Dermosifiliogr. 2012;103(6):478\u201387.","journal-title":"Actas Dermosifiliogr"},{"key":"1676_CR27","doi-asserted-by":"publisher","unstructured":"Mustasam A, Parza K, Ionescu F, Gullapalli K, Paravathaneni M, Kim Y, Sandstrom RE, Al Assaad M, Grass GD, Johnstone P, Eschrich S, Safa H, Chadha J, Souza GR, David J, Semaan A, Zacharias NM, Pettaway C, Giuliano AR, Spiess PE, Chahoud J. The Prognostic Role of HPV or p16INK4a Status in Penile Squamous Cell Carcinoma: A Meta-Analysis. J Natl Compr Canc Netw. 2025;23(2):e247078. https:\/\/doi.org\/10.6004\/jnccn.2024.7078. PMID: 39752880.","DOI":"10.6004\/jnccn.2024.7078"},{"issue":"10","key":"1676_CR28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","volume":"27","author":"FL Sand","year":"2018","unstructured":"Sand FL, Rasmussen CL, Frederiksen MH, Andersen KK, Kjaer SK. Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: A systematic review and Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2018;27(10):1123\u201332. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0322. Epub 2018 Jul 9. PMID: 29987099.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1676_CR29","doi-asserted-by":"crossref","unstructured":"Trias I, Saco A, Marimon L, L\u00f3pez Del Campo R, Manzotti C, Ordi O, Del Pino M, P\u00e9rez FM, Vega N, Al\u00f3s S, Mart\u00ednez A, Rodriguez-Carunchio L, Reig O, Jares P, Teixido C, Ajami T, Corral-Molina JM, Algaba F, Ribal MJ, Ribera-Cortada I, Rakislova N. P53 in Penile Squamous Cell Carcinoma: A Pattern-Based Immunohistochemical Framework with Molecular Correlation. Cancers (Basel). 2023; 11;15(10):2719.","DOI":"10.3390\/cancers15102719"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01676-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01676-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01676-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:12:56Z","timestamp":1751541176000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01676-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1676"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01676-5","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}